histori
vaccin
develop
synthet
vaccin
mileston
stark
contrast
tradit
vaccin
base
liveattenu
inactiv
microorgan
synthet
vaccin
safer
attenu
inactiv
microorgan
also
provid
opportun
vaccin
design
specif
purpos
first
gener
synthet
vaccin
larg
base
dna
recombin
technolog
genet
manipul
de
novo
gener
occasion
time
consum
costli
especi
era
genom
face
pandem
outbreak
infecti
diseas
acceler
simplifi
r
process
vaccin
develop
improv
method
synthet
vaccin
construct
base
protein
assembl
optim
employ
recent
develop
spytag
spycatch
techniqu
establish
protein
assembl
system
vaccin
gener
preprepar
subunit
protein
proof
principl
chose
dendrit
cell
dc
target
molecul
specif
model
antigen
gener
desir
vaccin
result
demonstr
new
vaccin
gener
way
hamper
individu
function
differ
vaccin
compon
effici
induc
b
cell
respons
protein
assembl
strategi
may
especi
use
highthroughput
antigen
screen
rapid
vaccin
gener
inc
creation
first
vaccin
cowpox
edward
jenner
late
eighteenth
centuri
immunolog
research
vaccin
focus
deconstruct
analysi
evalu
import
mechan
compon
vaccin
may
determin
effect
research
strategi
led
discoveri
larg
increas
number
function
element
differ
categori
includ
antigen
immun
modul
adjuv
deliveri
system
among
other
success
vaccin
usual
compos
multipl
element
list
given
multitud
choic
construct
differ
element
integr
function
whole
becom
new
challeng
field
although
genebas
synthet
recombin
dna
technolog
provid
great
flexibl
construct
certain
limit
still
exist
larg
fusion
protein
contain
multipl
function
element
occasion
technic
difficult
express
purifi
de
novo
gener
usual
tediou
long
process
especi
inadequ
face
emerg
pandem
infecti
diseas
screen
identif
antigen
crucial
vaccin
develop
face
difficulti
demand
instead
make
complex
fusionprotein
candid
vaccin
de
novo
everi
time
would
easier
faster
flexibl
effici
prepar
smaller
build
block
first
assembl
whole
need
achiev
goal
present
studi
develop
new
method
synthet
vaccin
construct
base
novel
proteinprotein
conjug
techniqu
spytagspycatch
conjug
techniqu
recent
develop
base
split
protein
streptococcu
pyogen
protein
contain
two
fragment
one
name
spytag
name
spycatch
combin
nearli
common
condit
spytag
spycatch
rapidli
effici
coval
conjug
isopeptid
bond
hypothes
conjug
techniqu
could
allow
us
achiev
goal
assembl
vaccin
base
differ
preprepar
function
compon
dendrit
cell
dc
target
emerg
import
strategi
vaccin
develop
due
increas
recognit
small
popul
cell
cellular
humor
immun
respons
ctype
lectin
endocyt
receptor
highli
express
dc
mice
dc
human
antibodi
develop
use
target
deliveri
molecul
conjug
antibodi
antigen
effici
deliv
dc
approach
found
superior
mediat
cytotox
cell
respons
antibodi
respons
histori
vaccin
develop
synthet
vaccin
mileston
stark
contrast
tradit
vaccin
base
liveattenu
inactiv
microorgan
synthet
vaccin
safer
attenu
inactiv
microorgan
also
provid
opportun
vaccin
design
specif
purpos
first
gener
synthet
vaccin
larg
base
dna
recombin
technolog
genet
manipul
de
novo
gener
occasion
time
consum
costli
especi
era
genom
face
pandem
outbreak
infecti
diseas
acceler
simplifi
r
process
vaccin
develop
improv
method
synthet
vaccin
construct
base
protein
assembl
optim
employ
recent
develop
spytag
spycatch
techniqu
establish
protein
assembl
system
vaccin
gener
preprepar
subunit
protein
proof
principl
chose
dendrit
cell
dc
target
molecul
specif
model
antigen
gener
desir
vaccin
result
demonstr
new
vaccin
gener
way
hamper
individu
function
differ
vaccin
compon
effici
induc
b
cell
respons
protein
assembl
strategi
may
especi
use
highthroughput
antigen
screen
rapid
vaccin
gener
inc
creation
first
vaccin
cowpox
edward
jenner
late
eighteenth
centuri
immunolog
research
vaccin
focus
deconstruct
analysi
evalu
import
mechan
compon
vaccin
may
determin
effect
research
strategi
led
discoveri
larg
increas
number
function
element
differ
categori
includ
antigen
immun
modul
adjuv
deliveri
system
among
other
success
vaccin
usual
compos
multipl
element
list
given
multitud
choic
construct
differ
element
integr
function
whole
becom
new
challeng
field
although
genebas
synthet
recombin
dna
technolog
provid
great
flexibl
construct
certain
limit
still
exist
larg
fusion
protein
contain
multipl
function
element
occasion
technic
difficult
express
purifi
de
novo
gener
usual
tediou
long
process
especi
inadequ
face
emerg
pandem
infecti
diseas
screen
identif
antigen
crucial
vaccin
develop
face
difficulti
demand
instead
make
complex
fusionprotein
candid
vaccin
de
novo
everi
time
would
easier
faster
flexibl
effici
prepar
smaller
build
block
first
assembl
whole
need
achiev
goal
present
studi
develop
new
method
synthet
vaccin
construct
base
novel
proteinprotein
conjug
techniqu
spytagspycatch
conjug
techniqu
recent
develop
base
split
protein
streptococcu
pyogen
protein
contain
two
fragment
one
name
spytag
name
spycatch
combin
nearli
common
condit
spytag
spycatch
rapidli
effici
coval
conjug
isopeptid
bond
hypothes
conjug
techniqu
could
allow
us
achiev
goal
assembl
vaccin
base
differ
preprepar
function
compon
dendrit
cell
dc
target
emerg
import
strategi
vaccin
develop
due
increas
recognit
small
popul
cell
cellular
humor
immun
respons
ctype
lectin
endocyt
receptor
highli
express
dc
mice
dc
human
antibodi
develop
use
target
deliveri
molecul
conjug
antibodi
antigen
effici
deliv
dc
approach
found
superior
mediat
cytotox
cell
respons
antibodi
respons
recent
vaccin
compos
antihuman
mab
fuse
tumor
antigen
demonstr
promis
biolog
activ
phase
clinic
trial
current
work
test
novel
method
proteinassembl
base
vaccin
construct
employ
optim
spytagspycatch
system
assembl
vaccin
compos
singlechain
antibodi
model
antigen
includ
model
tcell
epitop
chicken
ovalbumin
ova
tickborn
enceph
viru
envelop
protein
domain
tbev
new
synthet
vaccin
shown
fulli
function
gener
effici
cytotox
tcell
antibodi
respons
thu
proteinbas
synthet
vaccin
strategi
may
signific
improv
convent
genebas
synthet
vaccin
strategi
may
serv
use
platform
faster
easier
vaccin
develop
optim
spycatch
current
spytagspycatch
system
consist
aa
spytag
aa
spycatch
simplifi
system
engin
purpos
minim
immunogen
tri
truncat
spycatch
protein
maintain
conjug
activ
structur
analysi
found
aa
probabl
essenti
conjug
activ
immunogen
analysi
reveal
four
major
immun
epitop
nterminu
aa
aa
cterminu
aa
aa
figur
consid
togeth
perform
sever
truncat
shown
figur
truncat
delet
nterminu
aa
name
spycatcherdn
truncat
delet
nterminu
cterminu
aa
name
spycatcherdnc
truncat
spycatch
protein
express
escherichia
coli
purifi
ninta
chromatographi
figur
fulllength
truncat
spycatch
protein
use
immun
mice
fourteen
day
later
antibodi
level
sera
determin
elisa
shown
figur
antibodi
level
induc
spycatcherdn
spycatcherdnc
significantli
lower
induc
fulllength
spycatch
signific
differ
found
spycatcherdn
spycatcherdnc
next
test
effici
bind
truncat
spycatch
protein
spytag
fusion
protein
made
genet
fusion
spytag
singlechain
antibodi
murin
cterminu
shown
figur
signific
differ
bind
effici
spycatcherdn
fulllength
spycatch
consist
result
recent
studi
howev
bind
effici
spycatcherdnc
obvious
lower
fulllength
spycatch
therefor
spycatcherdn
chosen
studi
assembl
synthet
vaccin
use
optim
spytagspycatch
system
full
vaccin
usual
consist
least
immunoregulatori
function
unit
addit
antigen
modifi
singlechain
antibodi
use
function
unit
present
studi
ova
tbev
dna
sequenc
encod
model
antigen
includ
tcell
epitop
ovalbumin
bcell
epitop
tbev
genet
fuse
cterminu
spycatcherdn
scova
conjug
scova
would
result
fulli
function
vaccin
figur
express
freestyl
tm
cell
purifi
protein
chromatographi
figur
lane
scova
fusion
protein
express
e
coli
purifi
ninta
chromatographi
figur
lane
coval
bind
reaction
test
differ
condit
differ
molar
ratio
molar
ratio
scova
h
found
give
rise
optim
bind
effici
protein
sdspage
analysi
show
input
conjug
figur
lane
synthet
vaccin
purifi
protein
chromatographi
puriti
figur
lane
synthet
vaccin
bind
dc
vitro
vivo
test
dctarget
abil
synthet
fusion
protein
splenocyt
isol
wt
mice
incub
fusion
protein
isotypecontrol
protein
stain
fluoresc
secondari
antibodi
cell
analyz
flow
cytometri
shown
figur
convent
dc
gate
mhc
class
ii
high
high
cell
dc
dc
subset
gate
analyz
shown
figur
top
panel
fusion
protein
preferenti
bound
dc
rather
dc
immun
cell
data
shown
consist
assembl
cdna
encod
singl
chain
genet
fuse
spytag
cterminu
antigen
contain
epitop
tbev
fuse
cterminu
spycatcherdn
mix
amid
bond
effici
form
spytag
spycatch
b
synthet
vaccin
product
purif
purifi
mix
spycatcherdnova
tbev
molar
ratio
h
assembl
adduct
purifi
protein
chromatographi
effici
reaction
purifi
adduct
analyz
sdspage
specif
express
former
subset
dc
test
target
abil
vivo
wt
mice
immun
fusion
protein
togeth
cpg
poli
c
next
h
immun
drain
lymph
node
dln
isol
digest
form
singlecel
suspens
fusion
proteinbound
cell
visual
fluoresc
secondari
antibodi
stain
follow
flow
cytometri
preferenti
target
dc
confirm
figur
bottom
panel
thu
spytagspycatch
system
allow
assembl
spycatch
fusion
protein
without
influenc
dctarget
abil
synthet
vaccin
gener
enhanc
cytotox
tcell
respons
next
test
whether
synthet
vaccin
could
gener
effici
cytotox
tcell
respons
measur
ifnc
intracellular
stain
vivo
specif
kill
assay
wt
mice
immun
twice
fusion
protein
scova
protein
interv
c
use
adjuv
ifnc
intracellular
stain
assay
day
last
inject
splenocyt
isol
immun
mice
stimul
mgml
peptid
ubottom
plate
h
ifncproduc
cell
stain
analyz
flow
cytometri
splenocyt
mice
show
significantli
higher
percentag
ifncproduc
cell
compar
splenocyt
scova
mice
figur
vivo
specif
kill
assay
day
secondari
inject
target
cell
equal
mixtur
ova
peptideload
cfsehigh
label
splenocyt
nonload
cfselow
label
splenocyt
transfer
immun
mice
next
h
later
proport
cfselabel
cell
spleen
analyz
significantli
higher
specif
kill
rate
found
mice
immun
vaccin
synthet
vaccin
induc
better
antigenspecif
antibodi
respons
shown
target
antigen
induc
strong
antibodi
respons
presenc
adjuv
next
test
whether
synthet
elicit
better
antibodi
respons
antigen
tbev
wt
mice
immun
twice
pmol
fusion
protein
scova
protein
togeth
c
adjuv
interv
seven
day
last
vaccin
mice
bled
antitbev
antibodi
measur
elisa
compar
scova
control
vaccin
elicit
significantli
increas
antibodi
respons
tbev
figur
thu
synthet
dctarget
vaccin
effici
induc
tand
bcell
respons
success
vaccin
integr
function
whole
compos
differ
element
discoveri
effect
antigen
immunomodulatori
molecul
major
challeng
field
vaccin
develop
modern
immunolog
genom
provid
larg
amount
candid
simpl
rapid
effici
experiment
screen
optim
composit
vaccin
gener
demand
especi
face
pandem
outbreak
infect
sarscov
influenza
merscov
tradit
de
novo
gener
genebas
synthet
vaccin
time
consum
costli
present
studi
base
spytagspycatch
techniqu
develop
novel
method
vaccin
construct
protein
assembl
base
preprepar
vaccin
compon
employ
techniqu
construct
dctarget
vaccin
found
highli
effici
induc
tand
bcell
respons
although
strategi
still
reli
genet
manipul
protein
product
requir
synthes
larg
complex
fusion
protein
de
novo
everi
time
strategi
produc
smaller
protein
compon
build
block
easier
faster
blockbuild
strategi
may
allow
peopl
construct
variou
formul
vaccin
conveni
effici
need
approach
may
simplifi
whole
process
vaccin
gener
acceler
antigen
screen
verif
figur
addit
certain
vaccin
compon
build
block
may
easili
reus
construct
vaccin
differ
method
develop
construct
synthet
vaccin
tradit
way
genet
manipul
provid
great
flexibl
howev
de
novo
gener
usual
take
long
time
occasion
difficult
express
larg
molecul
chemic
conjug
offer
altern
fast
way
overcom
shortcom
mention
howev
chemic
conjug
process
usual
easili
control
result
poor
homogen
term
degre
conjug
number
conjug
site
isopeptid
bond
amid
bond
form
sidechain
amin
lysin
sidechain
carboxyl
group
either
glutam
aspart
bond
shown
use
proteinprotein
coupl
protein
modif
spytagspycatch
recent
develop
found
highli
effici
sitespecif
protein
conjug
impel
limit
current
method
vaccin
construct
inspir
concept
synthet
vaccinolog
hypothes
new
techniqu
might
use
easili
precis
assembl
differ
vaccin
compon
protein
level
approach
may
possess
sever
advantag
contrast
genet
manipul
system
gener
whole
vaccin
de
novo
instead
produc
differ
protein
compon
assembl
need
method
may
thu
significantli
reduc
time
spent
cost
especi
mani
design
need
test
contrast
chemic
conjugationbas
approach
system
allow
quantit
sitespecif
instal
antigen
design
posit
antibodi
influenc
antibodytarget
abil
spytag
spycatch
effici
react
form
stabl
coval
bond
divers
condit
spytag
reactiv
matter
nterminu
cterminu
intern
site
protein
therefor
offer
greater
flexibl
split
proteinderiv
system
intein
sortas
tag
system
addit
recent
work
howarth
group
optim
system
potenti
provid
advantag
spycatch
shorten
ktag
allow
spytag
ktag
form
peptidepeptid
ligat
thu
new
system
could
reduc
influenc
spycatch
immunogen
spytagandktag
system
allow
cycl
conjug
enabl
assembl
vaccin
multipl
compon
proteinbas
adjuv
multival
antigen
short
ktag
make
highthroughput
screen
epitop
feasibl
short
ktagepitop
fusion
peptid
easili
prepar
total
synthesi
result
present
studi
show
optim
spycatcherdn
exhibit
much
lower
immunogen
wildtyp
spycatch
without
influenc
abil
bind
antigencontain
fusion
protein
spycatcherdnova
also
effici
bind
without
affect
target
abil
either
vitro
vivo
subsequ
result
anim
studi
show
adduct
vaccin
elicit
enhanc
tcell
bcell
respons
furthermor
new
method
highli
translat
fact
unpublish
data
demonstr
use
efficaci
construct
vaccin
summari
establish
conveni
effici
platform
conjug
antigen
interest
specif
antibodi
use
optim
spytagspycatch
system
platform
could
use
antigen
screen
vaccin
develop
infecti
diseas
cancer
furthermor
use
method
probabl
limit
vaccin
develop
may
broader
applic
antibodi
recombin
protein
extens
studi
anim
clinic
studi
variou
diseas
prevent
therapeut
purpos
strategi
propos
current
studi
may
provid
easi
effici
proteinengin
method
gener
bispecif
antibodi
produc
multifunct
fusion
protein
antibodi
mice
femal
mice
week
old
purchas
vital
river
laboratori
anim
technolog
co
beij
china
mice
hous
specif
pathogenfre
condit
anim
care
facil
institut
biophys
chines
academi
scienc
anim
experi
perform
accord
guidelin
institut
biophys
chines
academi
scienc
use
protocol
approv
institut
laboratori
anim
care
use
committe
clone
express
purif
fusion
protein
fulllength
spycatch
express
plasmid
kindli
provid
dr
mark
howarth
univers
oxford
uk
dna
sequenc
truncat
form
spycatch
first
amplifi
pcr
use
follow
primer
common
forward
primer
gattacgacatcccaacgaccgaaaacctgtattttcagggcgatagtgctac
revers
primer
cgcggatccttaat
taactgtaaaggtaatagcagttgct
spycatcherdn
cgcggatccttaaatatgagcgtcacctttagttgcttt
spycatcherdnc
tag
code
sequenc
ad
secondari
pcr
use
ggaattccatatgtcgtactaccatcacc
atcaccatcacgattacgacatcccaa
bold
font
indic
ndei
bamhi
site
underlin
letter
encod
tobacco
etch
viru
tev
proteas
cleavag
site
tag
pcr
product
clone
use
ndei
bamhi
site
protein
express
compet
e
coli
cell
transform
respect
plasmid
singl
coloni
pick
cultur
ml
lb
overnight
cultur
amplifi
ml
induc
mm
iptg
h
bacteri
cultur
harvest
lyse
target
protein
purifi
use
ninta
agaros
column
comwin
biotech
beij
china
accord
manufactur
protocol
gener
spycatcherdnova
tbev
express
plasmid
cdna
encod
tbev
pcr
amplifi
plasmid
tbev
provid
dr
xiaop
kang
institut
microbiolog
epidemiolog
academi
militari
medic
scienc
china
g
linker
ova
epitop
chicken
ovalbumin
siinfekl
ad
nterminu
pcr
primer
use
pcr
follow
oe
f
ccgctcgagggcggtggtggcagccagcttgagagtataatcaactttgaaaaac
tgactgaatggacatac
acaatgtgcg
oe
r
ccgcgagctcttatca
tttttggaaccattg
bold
font
indic
xhoi
saci
site
spycatcherdn
fragment
amplifi
use
primer
dnscf
gcaattccatatgtc
gtactaccatcac
dnscr
ccgctcgagaatatgagcgtcaccttta
g
bold
font
indic
ndei
xhoi
site
spycatcherdn
ova
tbev
fragment
ligat
clone
ndei
saci
site
express
purif
spycatcherdnova
tbev
protein
perform
describ
plasmid
encod
dna
sequenc
variabl
region
heavi
light
chain
clone
kindli
provid
dr
ralph
steinman
rockefel
univers
usa
singl
chainencod
dna
pcr
amplifi
use
follow
primer
f
gcg
cgtacggaggtgaagctgttggaatc
r
gcgttcgaaccgttt
caattccagcttgg
dna
clone
express
plasmid
lonza
basel
switzerland
iggk
lead
sequenc
human
igg
fc
sequenc
use
bsiwi
bstbi
bold
font
spytagencod
sequenc
gctcacatcgtgatggtggacgcctacaagcccaccaag
gsgesg
linker
ggatccggcgagtccggc
genet
fuse
cterminu
human
igg
fc
fragment
pcr
construct
final
plasmid
figur
perspect
protein
assemblybas
synthet
vaccin
r
r
vaccin
cancer
infecti
diseas
especi
era
big
data
mani
function
unit
immun
molecul
antigen
avail
screen
optim
convent
way
left
make
synthet
vaccin
usual
complet
depend
de
novo
construct
combin
made
individu
time
consum
costli
take
advantag
protein
assemblybas
method
right
vaccin
compon
prepar
simpli
assembl
full
vaccin
need
procedur
could
easier
faster
flexibl
effici
ag
antigen
vivo
assay
wt
mice
inject
subcutan
tail
base
pmol
adduct
isotypecontrol
antibodi
h
inguin
dln
collect
digest
form
singlecel
suspens
cell
stain
antifccr
mab
follow
peconjug
antihuman
igg
antibodi
stain
flow
cytometri
analysi
elisa
microtit
plate
corn
life
scienc
tewksburi
usa
coat
mgml
mlwell
fulllength
spycatch
tbev
protein
carbon
buffer
ph
overnight
wash
away
unbound
protein
plate
incub
pb
contain
fb
h
serial
dilut
serum
sampl
immun
mice
ad
incub
h
hrplabel
antimous
igg
use
detect
antibodi
zhong
shangolden
bridg
biolog
technolog
co
ltd
beij
china
plate
visual
ad
ml
tmb
ebiosci
read
nm
use
spectramax
plu
molecular
devic
sunnyval
ca
usa
intracellular
cytokin
stain
assay
wt
mice
subcutan
immun
twice
pmol
scova
along
mg
invitrogen
life
technolog
beij
china
mg
poli
c
invivogen
san
diego
ca
usa
adjuv
interv
five
day
secondari
vaccin
spleen
immun
mice
harvest
process
singlecel
suspens
splenocyt
cellswel
triplic
restimul
ubottom
plate
mgml
peptid
siinfekl
chinapeptid
suzhou
china
h
presenc
brefeldin
mgml
co
restimul
cell
first
surfac
stain
apcconjug
antimous
antibodi
fixat
permeabil
intracellular
stain
ifnc
reagent
antibodi
purchas
ebiosci
manufactur
protocol
follow
surfac
intracellular
stain
vivo
cytotox
assay
wt
mice
immun
subcutan
pmol
scova
along
poli
c
adjuv
describ
five
day
secondari
vaccin
immun
mice
inject
intraven
peptidepuls
target
cell
vivo
kill
briefli
congen
splenocyt
cellsml
puls
mgml
peptid
h
one
wash
pb
cell
label
mm
cfse
cfse
high
invitrogen
carlsbad
ca
usa
min
fb
immedi
ad
termin
label
reaction
cell
wash
twice
pb
use
meanwhil
unpuls
splenocyt
label
mm
cfse
cfse
low
follow
procedur
mixtur
cfse
high
cfse
low
cell
cell
popul
cotransf
immun
mice
twenti
hour
later
spleen
harvest
singlecel
suspens
prepar
analyz
flow
cytometri
percentag
specif
kill
evalu
follow
formula
specif
kill
surviv
surviv
number
target
cell
remain
number
unpuls
target
cell
remain
protein
structur
immunogen
analysi
bepipr
linear
epitop
predict
use
immunogen
analysi
crystal
structur
data
rcsb
protein
data
bank
use
structur
analysi
statist
analysi
data
analyz
use
unpair
twotail
test
graphpad
prism
statist
softwar
graphpad
softwar
inc
san
diego
ca
usa
valu
p
consid
statist
signific
p
p
p
